Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450

Bakshi, 2002, Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRF2) receptors in lateral septum or CRF1 receptors in amygdala, J. Neurosci., 22, 2926, 10.1523/JNEUROSCI.22-07-02926.2002 Bilezikjian, 1983, Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3′, 5′-monophosphate in cultured anterior pituitary cells, Endocrinology, 113, 657, 10.1210/endo-113-2-657 Bissette, 2001, Effects of sertraline on regional neuropeptide concentrations in olfactory bulbectomized rats, Pharmacol. Biochem. Behav., 69, 269, 10.1016/S0091-3057(01)00513-5 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 Chaki, 1999, In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001, Eur. J. Pharmacol., 371, 205, 10.1016/S0014-2999(99)00120-X Chaki, 2002, R278995/CRA0450, a novel selective CRH1 receptor antagonist: receptor binding, signal transduction, functional activity and ex-vivo autoradiography, Abstr.-Soc. Neurosci., 683.2 Deak, 1999, The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress, Endocrinology, 140, 79, 10.1210/en.140.1.79 De Souza, 1987, Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution, J. Neurosci., 7, 88, 10.1523/JNEUROSCI.07-01-00088.1987 Detke, 1995, Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants, Psychopharmacology, 121, 66, 10.1007/BF02245592 Dunn, 1990, Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?, Brain Res. Rev., 15, 71, 10.1016/0165-0173(90)90012-D Felgner, 1987, Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure, Proc. Natl. Acad. Sci. U. S. A., 84, 7413, 10.1073/pnas.84.21.7413 Griebel, 1998, Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents, Psychopharmacology, 138, 55, 10.1007/s002130050645 Griebel, 2002, J. Pharmacol. Exp. Ther., 301, 333, 10.1124/jpet.301.1.333 Grigoriadis, 1996, 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2α receptors, Mol. Pharmacol., 50, 679 Guimaraes, 1991, Anxiolytic effect in the elevated plus-maze of the NMDA receptor AP7 microinjected into the dorsal periaqueductal grey, Psychopharmacology, 103, 91, 10.1007/BF02244080 Gully, 2002, J. Pharmacol. Exp. Ther., 301, 322, 10.1124/jpet.301.1.322 Gutman, 2000, Corticotropin-releasing factor antagonists as novel therapeutics, Drug Future, 25, 923, 10.1358/dof.2000.025.09.665577 Gutman, 2003, The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress, J. Pharmacol. Exp. Ther., 304, 874, 10.1124/jpet.102.042788 Hammack, 2002, The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress, J. Neurosci., 22, 1020, 10.1523/JNEUROSCI.22-03-01020.2002 Hauger, 2003, International union of pharmacology: XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands, Pharmacol. Rev., 55, 21, 10.1124/pr.55.1.3 Heinrichs, 1992, Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action, Brain Res., 581, 190, 10.1016/0006-8993(92)90708-H Heinrichs, 1997, Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior, Regul. Pept., 71, 15, 10.1016/S0167-0115(97)01005-7 Heinrichs, 2002, Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist, Neuropsychopharmacology, 27, 194, 10.1016/S0893-133X(02)00299-3 Herbert, 1985, 51 Holsboer, 1984, Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression, New Engl. J. Med., 311, 1127, 10.1056/NEJM198410253111718 Kamei, 1996, (+)SKF-10,047 and dextromethorphan ameliorate conditioned fear stress via dopaminergic systems linked to phenytoin-regulated sigma 1 sites, Eur. J. Pharmacol., 309, 149, 10.1016/0014-2999(96)00346-9 Kinsora, 1998, Effects of igmesine in preclinical anti-depressant test, Abstr.-Soc. Neurosci., 24, 291.3 Kostich, 1998, Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2 gamma receptor, Mol. Endocrinol., 12, 1077, 10.1210/me.12.8.1077 Leadbetter, 1999, Igmesine: a novel antidepressant, Biol. Psychiatry, 45, 76S Lovenberg, 1995, Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain, Proc. Natl. Acad. Sci. U. S. A., 92, 836, 10.1073/pnas.92.3.836 Lundkvist, 1996, A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity, Eur. J. Pharmacol., 309, 195, 10.1016/0014-2999(96)00337-8 Menzaghi, 1994, Characterization of a novel and potent corticotropin-releasing factor antagonist in rats, J. Pharmacol. Exp. Ther., 269, 564 Millan, 2001, Anxiolytic properties of the selective, nonpeptidergic CRF1 antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent, Neuropsychopharmacology, 25, 585, 10.1016/S0893-133X(01)00244-5 Mudunkotuwa, 1996, Desipramine administration in the olfactory bulbectomized rat: changes in brain β-adrenoceptor and 5-HT2A binding sites and their relationship to behavior, Br. J. Pharmacol., 117, 1481, 10.1111/j.1476-5381.1996.tb15310.x Nemeroff, 1984, Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients, Science, 226, 1342, 10.1126/science.6334362 Noda, 2000, Neurosteroids ameliorate conditioned fear stress: an association with sigma1 receptors, Neuropsychopharmacology, 23, 276, 10.1016/S0893-133X(00)00103-2 Okuyama, 1993, NE-100, a novel sigma receptor ligand: in vivo tests, Life Sci., 53, PL285, 10.1016/0024-3205(93)90588-T Okuyama, 1999, Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001, J. Pharmacol. Exp. Ther., 289, 926 Owen, 1991, Physiology and pharmacology of corticotropin releasing factor, Pharmacol. Rev., 43, 425 Perrin, 1995, Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart, Proc. Natl. Acad. Sci. U. S. A., 92, 2969, 10.1073/pnas.92.7.2969 Rivier, 1986, Mediation by corticotropin-releasing factor (CRF) of adrenohypophysial hormone secretion, Annu. Rev. Physiol., 48, 475, 10.1146/annurev.ph.48.030186.002355 Ronan, 2000, CRF in the learned helplessness animal model of depression: acute and prior administration of CRF causes escape deficits in rats similar to those induced by inescapable stress, Abstr.-Soc. Neurosci., 26, 2266 Shibata, 1984, Effects of chronic administration of antidepressants on mouse-killing behavior (muricide) in olfactory bulbectomized rats, Pharmacol. Biochem. Behav., 21, 225, 10.1016/0091-3057(84)90219-3 Skutella, 1998, Corticotropin-releasing hormone receptor (type 1) antisense targeting reduces anxiety, Neuroscience, 85, 795, 10.1016/S0306-4522(97)00682-9 Steckler, 1999, Corticotropin-releasing hormone receptor subtypes and emotion, Biol. Psychiatry, 46, 1480, 10.1016/S0006-3223(99)00170-5 Steckler, 2002, Antagonism of stress-induced anxiety and antidepressant-like profile of the selective CRH1 antagonist R278995/CRA0450, Abstr.-Soc. Neurosci., 683.1 Takahashi, 2001, Antagonism of CRF2 receptor produces anxiolytic behavior in animal models of anxiety, Brain Res., 902, 135, 10.1016/S0006-8993(01)02405-2 Takamori, 2001, Involvement of corticotropin-releasing factor subtype I receptor in the acquisition phase of learned helplessness in rats, Life Sci., 69, 1241, 10.1016/S0024-3205(01)01217-6 Taylor, 1988, Corticotropin-releasing hormone, New Engl. J. Med., 319, 213, 10.1056/NEJM198807283190405 Thorne, 1988, Memory deficit in passive-avoidance learning in bulbectomized Long–Evans hooded rats, Physiol. Behav., 44, 339, 10.1016/0031-9384(88)90035-2 Timpl, 1998, Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1, Nat. Genet., 19, 162, 10.1038/520 Ukai, 1998, Beneficial effects of acute and repeated administrations of σ receptor agonists on behavioral despair in mice exposed to tail suspension, Pharmacol. Biochem. Behav., 61, 247, 10.1016/S0091-3057(98)00093-8 Urani, 2001, The antidepressant-like effect induced by σ1-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test, J. Pharmacol. Exp. Ther., 298, 1269 Vale, 1981, Characterization of a 41-amino acid residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin, Science, 213, 1394, 10.1126/science.6267699 Zobel, 2000, Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated, J. Psychiat. Res., 34, 171, 10.1016/S0022-3956(00)00016-9